Virpax Pharmaceuticals News

Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 28 16:10 ET

Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 18 17:29 ET

Virpax Pharmaceuticals | 10-K/A: Annual report (Amendment)

Oct 10 17:11 ET

Virpax Pharmaceuticals | 10-K/A: Annual report (Amendment)

Oct 10 17:10 ET

Virpax Pharmaceuticals | 8-K/A: Current report (Amendment)

Oct 9 17:02 ET

Virpax Pharmaceuticals | 8-K: Current report

Oct 7 17:15 ET

Virpax Pharmaceuticals | 8-K: Current report

Oct 4 16:35 ET

Virpax Pharmaceuticals | 8-K: Current report

Oct 3 16:46 ET

Virpax Pharmaceuticals | 8-K: Current report

Oct 3 16:36 ET

Virpax Pharmaceuticals | 8-K: Current report

Sep 25 16:15 ET

Virpax Pharmaceuticals | 8-K: Current report

Sep 17 16:15 ET

Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Aug 13 09:07 ET

Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2024 SECOND QUARTER RESULTS AND RECENT DEVELOPMENTS

Aug 13 07:37 ET

Virpax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 12 16:32 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 30 17:31 ET

Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Jul 29 16:37 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 26 16:34 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 24 07:49 ET

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Su Judy

Jul 15 18:44 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 15 08:04 ET